Search
Zinc gluconate
go.drugbank.com/drugs/DB11248ApprovedInvestigationalVet approvedZinc gluconate is a generally recognized as safe (GRAS) substance by FDA [L2081]. … suggest that administration of zinc along with new low osmolarity oral rehydration solutions/salts (oral rehydration solution), may reduce both the duration and severity of diarrheal episodes for up to 12
Mixtures: FERROZINC - G SURUP, 100 ML, AVi VITAMIN C 1000 mg with Zinc, Real Ginger, Honey, Lemon and LemongrassProducts: Zinc (gluconate) 10 Mg Tablets, ZINC 50 MG.Lamotrigine
go.drugbank.com/drugs/DB00555ApprovedInvestigationalIt is approved for use in more than 30 countries.[A191350] Lamotrigine has relatively few side-effects and does not require laboratory monitoring.
Categories: Heterocyclic Compounds, 1-RingProducts: LAMEP 100 MG, LAMETEC 100 MGOctasulfur
go.drugbank.com/drugs/DB09353ApprovedPeople take sulfur by mouth for shortness of breath, allergies, swelling in the back of the throat (pharyngitis), high cholesterol, clogged arteries, menopause, and upper respiratory tract infections like
Mixtures: Se 10-5 Ss, Sulfatol 10-4 Cleansing padsProducts: Overnight Spot Treatment, Sulphur Ont 10%Ibandronate
go.drugbank.com/drugs/DB00710ApprovedInvestigational[A203138] Ibandronate was granted FDA approval on 16 May 2003.[L13805]
Mixtures: IBAMIN D3 150 MG/2800 IU FİLM KAPLI TABLET, 3 ADET, İBAMIN D3 150 MG/2800 IU GRANÜL İÇEREN SAŞE ,3 SAŞEProducts: IDENA 150 MG, IBANOS 150 MG FILM KAPLI TABLET, 1 ADETTobramycin
go.drugbank.com/drugs/DB00684ApprovedInvestigational[A232294, A232349, L32739, L32749] Tobramycin was approved by the FDA in 1975 and is currently available in a variety of forms for administration by inhalation, injection, and external application to … [A232294, A232299, L32739] However, tobramycin can also be administered intravenously and topically to treat a variety of infections caused by susceptible bacteria.
Mixtures: TOBRALOT 5 MG+3 MG/ML GÖZ DAMLASI, SÜSPANSİYON, 1 ADET, DEXAVITAL TOBRAMICIDADEXAMETASONA(3 MG+1MG)/MLSynonyms: O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamineRofecoxib
go.drugbank.com/drugs/DB00533ApprovedWithdrawnRofecoxib has a half-life of 17 hours and its mean oral bioavailability at therapeutically recommended doses of 125, 25, and 50 mg is approximately 93%. … Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C8, and Prostaglandin G/H synthase 1 are known to metabolize rofecoxib.
Categories: Heterocyclic Compounds, 1-RingProducts: REOX 12.5 MG TABLET, 14 ADET, ARTROX 12..5 MG TABLETASDasatinib
go.drugbank.com/drugs/DB01254ApprovedInvestigational[A2226] The use of dasatinib was first approved by the FDA in 2006.[L45171,L45186] … BCR-ABL is associated with the uncontrolled activity of the ABL tyrosine kinase and is involved in the pathogenesis of CML and 15-30% of ALL cases.
Categories: Heterocyclic Compounds, 1-RingSynonyms: N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamideCanakinumab
go.drugbank.com/drugs/DB06168ApprovedInvestigationalCanakinumab binds to human IL-1β and neutralizes its inflammatory activity by blocking its interaction with IL-1 receptors, but it does not bind IL-1alpha or IL-1 receptor antagonist (IL-1ra). … , anakinra, which must be injected daily and which is often poorly tolerated by patients.
Categories: Interleukin-1 Blockers, Interleukin-1β BlockersProducts: İLARİS 150 MG/ML ENJEKSİYONLUK ÇÖZELTİ, 1 ADET, ILARIS® SOLUCIÓN INYECTABLE 150 MG/ MLAvelumab
go.drugbank.com/drugs/DB11945ApprovedInvestigational[A261496] On September 18 and December 18 of the same year, it was also granted approval by EMA [L48126] and Health Canada,[L48171] respectively. … [A261496] Avelumab was first approved by the FDA on March 23, 2017.
Categories: PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors, PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitorsProducts: BAVENCIO 200 MG/10 ML IV İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 1 FLAKON, BAVENCIO 200 mg/10mL concentrate for solution for infusionCoagulation Factor IX Human
go.drugbank.com/drugs/DB13152ApprovedInvestigationalFactor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.
Mixtures: COFACT 250 IU/10 ML IV ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 1 ADET, COFACT 500 IU/20 ML IV ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 1 ADETProducts: PROFILNINE FOR INJECTION 1000 iu/10 ml, PROFILNINE FOR INJECTION 1500 iu/10 ml